I think it was more like ensuring the capacity to do it was in place. Things like bioreactors aren't overly specialized. As well as it went, it wasn't overly a

I think it was more like ensuring the capacity to do it was in place. Things like bioreactors aren't overly specialized. As well as it went, it wasn't overly ambitious. A few billions of dollars probably could have accelerated widespread availability by months (I'm thinking mostly about producing earlier, with the risk that the production would end up as waste if the vaccine didn't prove out).